{"id":384,"date":"2017-01-13T10:05:44","date_gmt":"2017-01-13T10:05:44","guid":{"rendered":"https:\/\/www.cochranelab.com\/?page_id=384"},"modified":"2025-11-13T13:45:36","modified_gmt":"2025-11-13T13:45:36","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.cochranelab.com\/?page_id=384","title":{"rendered":"Publications"},"content":{"rendered":"\n\n\t

Publications<\/em><\/strong><\/h2>\n

(Click titles for link to publishers website; \u22a5 = equal contribution; * = corresponding authors)<\/p>\n

 <\/p>\n41. Novel Synthetic Strategies Towards Analogues of Cadaside and Malacidin Antibiotic Peptides<\/strong><\/em><\/a>\nK. Webhofer, D. Naidu, M. Karak,\u00a0S. A. Cochrane<\/strong>, C. J. Morris, R. Dickman*\nBiomolecules<\/em>\u00a02025<\/strong>, 15<\/i>, 1497\n\n\n\n40. Lipid II Unlocked: Strategies for Obtaining a Major Antibiotic Target<\/strong><\/em><\/a>\nL. J. Tyrie, M. Karak,* S. A. Cochrane*<\/strong>\nChem. Commun.<\/em>\u00a02025<\/strong>, 61<\/em>, 11787\n\"\"<\/a>\n\n\n39. Hijacking the Electron Train: Menaquinone-Binding Antimicrobial Peptides<\/strong><\/em><\/a>\nE. J. Matheson, S. A. Cochrane*<\/strong>\nChemBioChem<\/em> 2025<\/strong>, 26<\/em>, e202500478\n\"\"<\/a>\n38. Novltex: A New Class of Antibiotics with Potent Activity Against Multidrug-Resistant Bacterial Pathogens – Design, Synthesis and Biological Evaluation<\/a><\/strong><\/em>\nE. Malkawi, A. Parmar, S. Das, E. Newire, C. M. Jones, K. A. Morrison, M. Karak, F. Blanc, N. Harper, R. Lakshminarayanan, N. K. Verma, J. Unsworth, S. A. Cochrane<\/strong>, W. Hope, I. Singh*\nJ. Med. Chem.<\/em> 2025<\/strong>, 68<\/em>, 19143\n

 <\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

37. Chemical Diversification of Polyprenyl Quinones for Mechanistic Studies on Menaquinone-Binding Peptide Antibiotics<\/strong><\/em><\/a><\/p>\n

E. M. Matheson, R. A. M. van Beekveld, P. Innocenti, N. I. Martin., M. Weingarth,\u00a0S. A. Cochrane*<\/strong><\/p>\n

Chem. Sci.\u00a0<\/em>2025<\/strong>, 16<\/em>, \u00a013629-13635<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

36. Lipid-Modulated, Graduated Inhibition of N-Glycosylation Pathway Priming Suggests Wide Tolerance of ER Proteostasis to Stress<\/em><\/strong><\/a><\/p>\n

A. M. Giltrap, N. Morris, Y. Y. Dong, S. A. Cochrane<\/strong>, T. Krulle, S. Hoekman, M. Semmelroth, C. Wollnik, E. P. Carpenter, Y. Rudhard, J. Hollick, A. Parkes, B. G. Davis*<\/p>\n

ACS Cent. Sci.<\/i>\u00a02025<\/strong>, 11<\/i>, 107-115<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

35. A Novel Approach for the Synthesis of the Cyclic Lipopeptide Globomycin<\/em><\/strong><\/a><\/p>\n

S. J. Bann, S. A. Cochrane<\/strong>*<\/p>\n

RSC Med. Chem.<\/i>\u00a02025<\/strong>, 16<\/i>, 373-378<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

34. Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii<\/em><\/strong><\/a><\/p>\n

P. J. Alexander, L. B. Oyama, H. Olleik, F. Godoy Santos, S. O’Brien, A. Cookson, S. A. Cochrane<\/strong>, B. F. Gilmore, M. Maresca, S. A. Huws*<\/p>\n

NPJ Biofilms Microbiomes<\/em> 2024<\/strong>, 10<\/i>, 92<\/p>\n

 <\/p>\n

33. A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens <\/em><\/strong><\/a><\/p>\n

N. P. Buijs, H. C. Vlaming, I. Kotsogianni, M. Arts, J. J. Willemse, Y. Duan, F. M. Alexander, S. A. Cochrane<\/strong>, Tanja Schneider, Nathaniel I. Martin*<\/p>\n

Proc.\u00a0<\/em>Natl. Acad. Sci. USA<\/i>\u00a02024<\/strong>, 121,<\/em>\u00a0e2315310121<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

32. Discovery and derivatization of tridecaptin antibiotics with altered host specificity and enhanced bioactivity<\/em><\/strong><\/a><\/p>\n

N. V. Machushynets, K. Al Ayed, B. Terlouw, C. Du, N. Buijs, J. Willemse, S. S. Elsayed, J. Schill, V. Trebosc, M. Pieren, F. M. Alexander, S. A. Cochrane<\/strong>, M. R. Liles, M. H. Medema, N. I. Martin, G. P. van Wezel<\/p>\n

ACS Chem. Biol.<\/i>\u00a02024<\/strong>, 19<\/em>, 1106-1115<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

31. De novo design of cyclic peptide inhibitors of a bacterial membrane lipoprotein peptidases <\/em><\/strong><\/a><\/p>\n

T. W. Craven\u22a5, M. D. Nolan\u22a5, J. Bailey\u22a5,S. Olatunji, S. J. Bann, K. Bowen, N. Ostrovitsa, T. M. Da Costa, R. D. Ballantine, D. Weichert, P. M. Levine, L. J. Stewart, G. Bhardwaj, J. A. Geoghegan,* S. A. Cochrane<\/strong>,* E. M. Scanlan,* M. Caffrey,* D. Baker*<\/p>\n

ACS Chem. Biol.<\/i>\u00a02024<\/strong>, 19<\/em>, 1125-1130<\/p>\n

\"\"<\/a><\/p>\n

30. Plectasin kills bacteria by a Ca2+-sensitive supramolecular mechanism<\/em><\/strong><\/a><\/p>\n

S. Jekhmane, M. G. N. Derks, S. Maity, C. J. Slingerland, K. H. M. E. Tehrani, J. Medeiros-Silva, V. J. Charitou, \u00a0D. Ammerlaan, C. Fetz, N. A. Consoli, R. V. K. Cochrane, E. J. Matheson, M. van der Weijde, B. O. W. Elenbaas, F. Lavore, R. Cox, J. H. F. F. Lorent, M. Baldus, M. Kunzler, M. Lelli, S. A. Cochrane<\/strong>, N. I. Martin, W. H. Roos, E. Breukink*, M. Weingarth*\u00a0<\/p>\n

Nat. Microbiol.<\/em> 2024<\/strong>, 9<\/em>, 1778-1791<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

29. Optimizations of Lipid II Synthesis: An Essential Glycolipid Precursor in Bacterial Cell Wall Synthesis and a Validated Antibiotic Target<\/em><\/strong><\/a><\/p>\n

M. Karak, C. R. Cloonan, B. R. Baker, R. V. K. Cochrane, S. A. Cochrane*<\/strong><\/p>\n

Beilstein J. Org. Chem.<\/em> 2024<\/strong>, 20<\/em>, 220-227<\/p>\n

\"\"<\/p>\n

 <\/p>\n

28. Targeting membrane-bound bacterial cell wall precursors: A tried and true antibiotic strategy in nature and the clinic<\/em><\/strong><\/a><\/p>\n

N. P. Buijse\u22a5, E. J. Matheson\u22a5, S. A. Cochrane*<\/strong> and N. I. Martin*<\/p>\n

Chem. Commun.<\/em>\u00a02023<\/strong>, 59<\/em>, 7685-7703.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

27. Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues that Retain Full Antibacterial Activity<\/em><\/strong><\/a><\/p>\n

R. D. Ballantine\u22a5, K. Al Ayed\u22a5,\u00a0S. J. Bann,\u00a0M. Hoekstra, N. I. Martin* and S. A. Cochrane*<\/strong><\/p>\n

J. Med. Chem.<\/em>\u00a02023<\/strong>, 66<\/em>, 6002-6009.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

26. Synthesis and Structure-Activity Relationship Studies of N-Terminal Analogues of the Lipopeptide Antibiotics Brevicidine and Laterocidine<\/em><\/strong><\/a><\/p>\n

R. D. Ballantine\u22a5, K. Al Ayed\u22a5,\u00a0S. J. Bann,\u00a0M. Hoekstra, N. I. Martin* and S. A. Cochrane*<\/strong><\/p>\n

RSC Med. Chem.<\/em>\u00a02022<\/strong>,\u00a013<\/em>, 1640-1643.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

25. Synthetic Studies with the Brevicidine and Laterocidine Lipopeptide Antibiotics Including Analogues with Enhanced Properties and in vivo Efficacy<\/em><\/strong><\/a><\/p>\n

K. Al Ayed\u22a5, R. D. Ballantine\u22a5, M. Hoekstra, S. J. Bann, C. M. J. Wesseling, A. T. Bakker, Z. Zhong, Y-X Li, N. C. Br\u00fcchle, M. van der Stelt, S. A. Cochrane*<\/strong> and N. I. Martin*<\/p>\n

Chem. Sci.<\/em>\u00a02022<\/strong>,\u00a013<\/em>, 3563.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

24. Binding Studies Reveal Phospholipid Specificity and its Role in the Calcium-Dependent Mechanism of Action of Daptomycin<\/em><\/strong><\/a><\/p>\n

I. Kotsogianni, T. M. Wood, F. M. Alexander, S. A. Cochrane<\/strong> and N. I. Martin*<\/p>\n

ACS Infectious Diseases<\/em>,\u00a02021<\/strong>, 7<\/i>, 2612.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

 <\/p>\n

23. The Tridecaptins: Non-Ribosomal Peptides That Selectively Target Gram-Negative Bacteria<\/em><\/strong><\/a><\/p>\n

S. J. Bann, R. D. Ballantine and S. A. Cochrane*<\/strong><\/p>\n

RSC Med. Chem.<\/em>\u00a02021<\/strong>,\u00a012<\/em>, 538.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

22. Undecaprenol Kinase: Function, Mechanism and Substrate Specificity of a Potential Antibiotic Target<\/em><\/strong><\/a><\/p>\n

B. R. Baker, C. M. Ives, A. Bray, M. Caffrey* and S. A. Cochrane*<\/strong><\/p>\n

Eur. J. Med. Chem.<\/em>\u00a02021<\/strong>, 210<\/em>, 113062.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

21. From Plant to Probe: Semi-Synthesis of Labelled Undecaprenol Analogues Allows Rapid Access to Probes for Antibiotic Targets<\/em><\/strong><\/a><\/p>\n

R. V. K. Cochrane, F. M. Alexander, C. Boland, S. K. Fetics, M. Caffrey and S. A. Cochrane*<\/strong><\/p>\n

Chem. Commun.<\/em>, 2020<\/strong>, 56<\/em>, 8603.<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

20. Breaking Down the Cell Wall: Strategies for Antibiotic Discovery Targeting Bacterial Transpeptidases<\/em><\/strong><\/a><\/p>\n

S. A. Cochrane<\/strong> and C. T. Lohans*<\/p>\n

Eur. J. Med. Chem.<\/em>\u00a02020<\/strong>, 194<\/em>, 113062.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

19. Observation of the Unbiased Conformers of Putative DNA-Scaffold Ribosugars<\/em><\/strong><\/a><\/p>\n

C. Calabrese, I. Uriarte, A. Insausti, M. Vallejo-L\u00f3pez, F. J. Basterretxea, S. A. Cochrane<\/strong>, B. G. Davis*, F. Corzana*, and E. J. Cocinero*<\/p>\n

ACS Cent. Sci.<\/em>\u00a02020<\/strong>, 6<\/em>, 293.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

18. A Chemical-Intervention Strategy to Circumvent Peptide Hydrolysis by D-Stereoselective Peptidases<\/em><\/strong><\/a><\/p>\n

S. J. Bann, R. D. Ballantine, Y-X. Li, P-Y. Qian and S. A. Cochrane*<\/strong><\/p>\n

J. Med. Chem.<\/em>\u00a02019<\/strong>, 62<\/em>, 10466.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

17. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell Wall Precursor Lipid II<\/strong><\/em><\/a><\/p>\n

S. Chiorean, I. Antwi, D. W. Carney, I. Kotsogianni, A. M. Giltrap, F. M. Alexander, S. A. Cochrane<\/strong>, R. J. Payne, N. I. Martin, A. Henninot and J. C. Vederas*<\/p>\n

ChemBioChem<\/em>\u00a02019<\/strong>, 21<\/em>, 781.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

16. Tridecaptin-Inspired Antimicrobial Peptides with Activity Against Multidrug-Resistant Gram-Negative Bacteria<\/strong><\/em><\/a><\/p>\n

R. D. Ballantine, C. E. McCallion, E. Nassour, S. Tokajian and S. A. Cochrane*<\/strong><\/p>\n

Med. Chem. Commun.<\/em>\u00a02019<\/strong>, 10<\/i>, 484.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

15. Rational Design of New Cyclic Analogues of the Antimicrobial Lipopeptide Tridecaptin A1<\/strong><\/em><\/a><\/p>\n

R. D. Ballantine,\u00a0 Y-X. Li,\u00a0 P-Y. Qian\u00a0 and S. A. Cochrane*<\/strong><\/p>\n

Chem.\u00a0<\/i>Commun.<\/i> 2018<\/strong>, 54<\/em>, 10634.<\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

14. Insights into the Mechanism of Action of the Two-Peptide Lantibiotic Lacticin 3147<\/strong><\/em><\/a><\/p>\n

A. Bakhtiary, S. A. Cochrane<\/strong>, P. Mercier, R. T. McKay, M. Miskolzie, C. Sit and J. C. Vederas*<\/p>\n

J. Am.\u00a0<\/em>Chem. Soc.<\/i>\u00a02017<\/strong>,\u00a0139<\/em>, 17803.<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

Publications from PhD and postdoctoral work:<\/strong><\/p>\n

13. Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design<\/strong><\/em><\/a><\/p>\n

Y. Y. Dong, H. Wang, A. C. W. Pike, S. A. Cochrane<\/strong>, S. Hamedzadeh, F. J. Wyszy\u0144ski, S. R. Bushell, S. F. Royer, D. A. Widdick, A. Sajid, H. I. Boshoff, Y. Park, R. Lucas, W-M. Liu, S. S. Lee, T. Machida, L. Minall, S. Mehmood, K. Belaya, W-W. Liu, A. Chu, L. Shrestha, S. M.M. Mukhopadhyay, C. Strain-Damerell, R. Chalk, N. A. Burgess-Brown, M. J. Bibb, C. E. Barry 3rd, C. V. Robinson, D. Beeson, B. G. Davis* and E. P. Carpenter*.<\/p>\n

Cell<\/i>\u00a02018<\/strong>, 175<\/i>, 1045.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

 <\/p>\n

12.\u00a0The Antimicrobial Lipopeptide Tridecaptin A1<\/sub> Selectively Binds to Gram-Negative Lipid II<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong>, B. Findlay, A. Bakhtiary, J. Z. Acedo, W. M. Rodriguez-Lopez, P. Mercier and J. C. Vederas*<\/p>\n

Proc. Natl. Acad. Sci. USA\u00a0<\/em>2016<\/strong>,\u00a0113<\/em>, 11561<\/p>\n

\"Publications<\/p>\n

Publications figure showing the NMR solution-structure of the tridecaptin A1:lipid II complex\u00a0<\/em><\/p>\n

Recommended in F1000 Prime<\/em><\/a><\/p>\n

 <\/p>\n

11.\u00a0Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong> and J. C. Vederas*<\/p>\n

Med. Res. Rev.<\/em>\u00a02016<\/strong>,\u00a036<\/em>, 4<\/p>\n

 <\/p>\n

10.\u00a0Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity Against Gram-Negative Bacteria<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong>, X. Li, S. He, M. Yu, M. Wu and J. C. Vederas*<\/p>\n

J. Med.\u00a0<\/em>Chem.<\/i>\u00a02015<\/strong>,\u00a058<\/em>, 9779<\/p>\n

\"Synthesis<\/p>\n

9.\u00a0Total Synthesis and Stereochemical Assignment of the Antimicrobial Lipopeptide Cerexin A1<\/sub><\/em><\/strong><\/a><\/p>\n

S. A. Cochrane<\/strong>, R. R. Surgenor, K. M. W. Khey and J. C. Vederas*<\/p>\n

Org. Lett.<\/em>\u00a02015<\/strong>,\u00a017<\/em>, 5428<\/p>\n

\"Total<\/p>\n

8.\u00a0Studies on Tridecaptin B1<\/sub>, a New Tridecaptin Analogue with Activity Against Multidrug Resistant Gram-Negative Bacteria<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong>, C. T. Lohans, M. J. Van Belkum, M. Bels, and J. C. Vederas*<\/p>\n

Org. Biomol. Chem.\u00a0<\/em>2015<\/strong>,\u00a013<\/em>, 6073<\/p>\n

\"Studies<\/p>\n

2015 OBC Hot Article<\/a><\/em><\/strong><\/p>\n

 <\/p>\n

7.\u00a0Molecular Cloning and Characterization of Drimenol Synthase from Valerian (Valeriana officinalis)<\/strong><\/em><\/a><\/p>\n

M. Kwon, S. A. Cochrane<\/strong>, J. C. Vederas, and D. K. Ro*<\/p>\n

FEBS Lett.\u00a0<\/em>2014<\/strong>,\u00a0588<\/em>, 4597<\/p>\n

\"Publications<\/p>\n

Publications figure showing\u00a0proposed mechanism of drimenol synthase<\/em><\/p>\n

 <\/p>\n

6.\u00a0Unacylated Tridecaptin A1<\/sub> Acts as an Effective Sensitizer of Gram-Negative Bacteria to Other Antibiotics<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong> and J. C. Vederas*<\/p>\n

Int. J. Antimicrob. Agents<\/em> 2014<\/strong>, 44<\/em>, 493<\/p>\n

 <\/p>\n

5.\u00a0Key Residues in Octyl-tridecaptin A1<\/sub> Analogs Linked to Stable Secondary Structure in the Membrane<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong>, B. Findlay, J. C. Vederas and E. S. Ratemi*<\/p>\n

ChemBioChem<\/em>\u00a02014<\/strong>,\u00a015<\/em>, 1295<\/p>\n

\"Key<\/p>\n

 <\/p>\n

4.\u00a0Synthesis and Structure-Activity Relationship Studies of N-Terminal Analogues of the Antimicrobial Peptide Tridecaptin A1<\/sub><\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong>, C. T. Lohans, J. R. Brandelli, G. Mulvey, G. D. Armstrong and J. C. Vederas*<\/p>\n

J. Med. Chem.<\/em>\u00a02014<\/strong>, \u00a057<\/em>, 1127<\/p>\n

\"Synthesis<\/p>\n

3.\u00a0Biochemical, Structural and Genetic Characterization of Tridecaptin A1<\/sub>, an Antagonist of Campylobacter jejuni<\/strong><\/em><\/a><\/p>\n

C. T. Lohans, M. J. van Belkum, S. A.\u00a0Cochrane<\/strong>, Z. Huang, C. S. Sit, L. M. McMullen and J. C. Vederas*<\/p>\n

ChemBioChem <\/em>2014<\/strong>,\u00a015<\/em>, 243<\/p>\n

\"Publications<\/p>\n

Publications figure showing\u00a0putative tridecaptin A1 non-ribosomal peptide\u00a0synthetase\u00a0gene cluster<\/em><\/p>\n

 <\/p>\n

2.\u00a0Investigation of the Ring-Closing Metathesis of Peptides in Water<\/strong><\/em><\/a><\/p>\n

S. A. Cochrane<\/strong>, Z.\u00a0Huang and J. C. Vederas*<\/p>\n

Org. Biomol. Chem.\u00a0<\/em>2013<\/strong>, 11<\/em>, 630<\/p>\n

\"InvestigationOBC Hot Article<\/a><\/em><\/strong><\/p>\n

 <\/p>\n

1.\u00a0Solid Supported Chemical Synthesis of Both Components of the Lantibiotic Lacticin 3147<\/strong><\/em><\/a><\/p>\n

W. Liu, A. S. H. Chan, H. Liu, S. A.\u00a0Cochrane<\/strong>\u00a0and J. C. Vederas*<\/p>\n

J. Am. Chem. Soc.<\/em>\u00a02011<\/strong>,\u00a0133<\/em>, 14216<\/p>\n

\"Solid<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"File:UKRI<\/p>\n

\"File:UKRI-Logo<\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"The<\/p>\n

\"Major<\/p>\n

\"Department<\/p>\n

 <\/p>\n\n

 <\/p>\n\n","protected":false},"excerpt":{"rendered":"

Publications (Click titles for link to publishers website; \u22a5 = equal contribution; * = corresponding authors)   41. Novel Synthetic<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-384","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=\/wp\/v2\/pages\/384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=384"}],"version-history":[{"count":140,"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=\/wp\/v2\/pages\/384\/revisions"}],"predecessor-version":[{"id":1314,"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=\/wp\/v2\/pages\/384\/revisions\/1314"}],"wp:attachment":[{"href":"https:\/\/www.cochranelab.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}